Aihua Tan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Aihua Tan has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
Han Yan
Hubei University of Chinese Medicine, Wuhan, PR China
2 shared publicationsMiyuan Wang
Hubei Provincial Hospital of TCM (Affiliated Hospital of Hubei University of Chinese Medicine), Wuhan, Hubei, China
2 shared publications- Si-Miao Ran
HuangGang Hospital of TCM Affifiliated to Hubei University of Chinese Medicine, Huang Gang, Hubei, China
2 shared publications Simiao Ran
Guangxi Medical University, Nanning 530200, China
2 shared publicationsZiyu Song
Hubei University of Chinese Medicine, Wuhan, PR China
2 shared publications- Antonio Jimeno
UC Health Cancer Center, Aurora, Colorado
1 shared publication
Latest Publications
- Open Access
- 12 May 2023
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 14
Association of serum water-soluble vitamin exposures with the risk of metabolic syndrome: results from NHANES 2003-2006
Introduction: Existing evidence suggests an association between certain vitamins and metabolic syndrome (MetS), but few epidemiological studies have focused on the effects of multivitamin co-exposure on MetS. This study aims to investigate the associations of the individual or multiple water-soluble vitamins (i.e., vitamin C (VC), vitamin B9 (VB9), and vitamin B12 (VB12)) with co-exposure to MetS, as well as the dose-response relationships among them.Methods: A cross-sectional study was conducted by employing the National Health and Examination Surveys (NHANESs) 2003-2006. Multivariate-adjusted logistic regression models were used to explore the association between individual serum water-soluble vitamins and the risk of MetS and its components, including waist circumference, triglyceride, high-density lipoprotein, blood pressure, and fasting plasma glucose. Restricted cubic splines were performed to explore the dose-response relationships among them. The quantile g-computation method was adopted to explore the associations of multiple water-soluble vitamins co-exposure with MetS risk and MetS components.Results: A total of 8983 subjects were involved in the study, of whom 1443 were diagnosed with MetS. The MetS groups had a higher proportion of participants with age ≥60 years, BMI ≥30 kg/m2, and insufficient physical activity. Compared with the lowest quartile, the third (OR=0.67, 95% CI: 0.48, 0.94) and highest quartiles (OR=0.52, 95%CI: 0.35, 0.76) of VC were associated with lower MetS risk. Restricted cubic splines showed negative dose-response relationships among VC, VB9 and VB12, and MetS. Regarding MetS components, higher VC quartiles were associated with lower waist circumference, triglyceride, blood pressure, and fasting plasma glucose, while higher VC and VB9 quartiles were associated with higher high-density lipoprotein (HDL). Co-exposure to VC, VB9, and VB12 was significantly inversely associated with MetS, with ORs (95% CI) of 0.81 (0.74, 0.89) and 0.84 (0.78, 0.90) in the conditional and marginal structural models, respectively. Furthermore, we found that VC, VB9, and VB12 co-exposure were negatively associated with waist circumference and blood pressure, while VC, VB9, and VB12 co-exposure were positively associated with HDL.Conclusion: This study revealed negative associations of VC, VB9, and VB12 with MetS, while the high water-soluble vitamin co-exposure was associated with a lower MetS risk.
- 12 May 2023
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 14
Open AccessAssociation of serum water-soluble vitamin exposures with the risk of metabolic syndrome: results from NHANES 2003-2006
Introduction: Existing evidence suggests an association between certain vitamins and metabolic syndrome (MetS), but few epidemiological studies have focused on the effects of multivitamin co-exposure on MetS. This study aims to investigate the associations of the individual or multiple water-soluble vitamins (i.e., vitamin C (VC), vitamin B9 (VB9), and vitamin B12 (VB12)) with co-exposure to MetS, as well as the dose-response relationships among them.Methods: A cross-sectional study was conducted by employing the National Health and Examination Surveys (NHANESs) 2003-2006. Multivariate-adjusted logistic regression models were used to explore the association between individual serum water-soluble vitamins and the risk of MetS and its components, including waist circumference, triglyceride, high-density lipoprotein, blood pressure, and fasting plasma glucose. Restricted cubic splines were performed to explore the dose-response relationships among them. The quantile g-computation method was adopted to explore the associations of multiple water-soluble vitamins co-exposure with MetS risk and MetS components.Results: A total of 8983 subjects were involved in the study, of whom 1443 were diagnosed with MetS. The MetS groups had a higher proportion of participants with age ≥60 years, BMI ≥30 kg/m2, and insufficient physical activity. Compared with the lowest quartile, the third (OR=0.67, 95% CI: 0.48, 0.94) and highest quartiles (OR=0.52, 95%CI: 0.35, 0.76) of VC were associated with lower MetS risk. Restricted cubic splines showed negative dose-response relationships among VC, VB9 and VB12, and MetS. Regarding MetS components, higher VC quartiles were associated with lower waist circumference, triglyceride, blood pressure, and fasting plasma glucose, while higher VC and VB9 quartiles were associated with higher high-density lipoprotein (HDL). Co-exposure to VC, VB9, and VB12 was significantly inversely associated with MetS, with ORs (95% CI) of 0.81 (0.74, 0.89) and 0.84 (0.78, 0.90) in the conditional and marginal structural models, respectively. Furthermore, we found that VC, VB9, and VB12 co-exposure were negatively associated with waist circumference and blood pressure, while VC, VB9, and VB12 co-exposure were positively associated with HDL.Conclusion: This study revealed negative associations of VC, VB9, and VB12 with MetS, while the high water-soluble vitamin co-exposure was associated with a lower MetS risk.
- Open Access
- 17 October 2022
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2022, 1-10
Effect of Low-Frequency Electrical Stimulation Combined with Tonifying Kidney and Blood Pills on Uterine Rejuvenation after Abortion
Objective. This study aimed to observe the clinical efficacy of low-frequency electrical stimulation therapy combined with tonifying the kidney and activating blood pills to promote uterine recovery after abortion and its effect on heat-shock protein (HSP)70 and HSP90. Methods. All cases were women with early pregnancy who underwent an abortion at the Third Affiliated Hospital of Nanchang University from September 2019 to September 2020. They were divided into two groups in accordance with the principle of patient voluntariness: 237 cases in the experimental group and 143 cases in the control group. Patients in both groups were given low-frequency electrical stimulation after surgery. In addition, patients in the experimental group began to take the Dingkun pill orally (one pill per time, two times per day) from the first day of surgery and continued to take it until their menstruation returned to normal. Abdominal pain, the duration of vaginal bleeding, and the amount of bleeding were observed in both groups. Uterine size, endometrial thickness, and urinary human chorionic gonadotropin (HCG) status were also observed at 2 weeks postoperatively to determine preoperative and postoperative HSP70 and HSP90 serum levels. The time of menstrual resumption, menstrual period, and menstrual volume were observed and compared with preoperative menstruation. The occurrence of complications, such as a residual uterine cavity, uterine effusion, menstrual irregularities, and reproductive tract infections, during the follow-up period was also recorded in both groups. Results. Comparison of the endometrial thickness (mm) and uterine size (sum of the three diameters) on uterine adnexal ultrasound at 2-week postoperative review was better in the experimental group than in the control group ( ). No statistically significant difference was found between the two groups in terms of residual uterine cavity and blood accumulation in the uterine cavity and the results of the urine pregnancy test ( ). Serum HSP70 and HSP90 levels were significantly higher in the control group than in the experimental group 2 weeks after surgery ( ). Postoperative HSP70 and HSP90 levels were significantly higher than preoperative levels in both groups ( ). The degree of postoperative abdominal pain in the experimental group was less severe than that in the control group, and the duration was shorter ( ). No statistically significant differences were observed when comparing the duration of postoperative vaginal bleeding and the amount of bleeding ( ). The time of the first menstrual resumption and menstrual volume were more satisfactory in the experimental group than in the control group ( ). No adverse reactions occurred in either group of patients receiving treatment. Conclusion.Low-frequency electrical stimulation combined with tonifying the kidney and invigorating blood pills could effectively promote uterine rejuvenation after abortion, conducive to improving patients’ postoperative abdominal pain, promoting menstrual recovery and maintaining menstrual flow.
- 17 October 2022
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2022, 1-10
Open AccessEffect of Low-Frequency Electrical Stimulation Combined with Tonifying Kidney and Blood Pills on Uterine Rejuvenation after Abortion
Objective. This study aimed to observe the clinical efficacy of low-frequency electrical stimulation therapy combined with tonifying the kidney and activating blood pills to promote uterine recovery after abortion and its effect on heat-shock protein (HSP)70 and HSP90. Methods. All cases were women with early pregnancy who underwent an abortion at the Third Affiliated Hospital of Nanchang University from September 2019 to September 2020. They were divided into two groups in accordance with the principle of patient voluntariness: 237 cases in the experimental group and 143 cases in the control group. Patients in both groups were given low-frequency electrical stimulation after surgery. In addition, patients in the experimental group began to take the Dingkun pill orally (one pill per time, two times per day) from the first day of surgery and continued to take it until their menstruation returned to normal. Abdominal pain, the duration of vaginal bleeding, and the amount of bleeding were observed in both groups. Uterine size, endometrial thickness, and urinary human chorionic gonadotropin (HCG) status were also observed at 2 weeks postoperatively to determine preoperative and postoperative HSP70 and HSP90 serum levels. The time of menstrual resumption, menstrual period, and menstrual volume were observed and compared with preoperative menstruation. The occurrence of complications, such as a residual uterine cavity, uterine effusion, menstrual irregularities, and reproductive tract infections, during the follow-up period was also recorded in both groups. Results. Comparison of the endometrial thickness (mm) and uterine size (sum of the three diameters) on uterine adnexal ultrasound at 2-week postoperative review was better in the experimental group than in the control group ( ). No statistically significant difference was found between the two groups in terms of residual uterine cavity and blood accumulation in the uterine cavity and the results of the urine pregnancy test ( ). Serum HSP70 and HSP90 levels were significantly higher in the control group than in the experimental group 2 weeks after surgery ( ). Postoperative HSP70 and HSP90 levels were significantly higher than preoperative levels in both groups ( ). The degree of postoperative abdominal pain in the experimental group was less severe than that in the control group, and the duration was shorter ( ). No statistically significant differences were observed when comparing the duration of postoperative vaginal bleeding and the amount of bleeding ( ). The time of the first menstrual resumption and menstrual volume were more satisfactory in the experimental group than in the control group ( ). No adverse reactions occurred in either group of patients receiving treatment. Conclusion.Low-frequency electrical stimulation combined with tonifying the kidney and invigorating blood pills could effectively promote uterine rejuvenation after abortion, conducive to improving patients’ postoperative abdominal pain, promoting menstrual recovery and maintaining menstrual flow.
- Open Access
- 5 August 2022
- Published by Wolters Kluwer Health in Medicine
- Vol. 101 (31) , e29307
A systematic review of the efficacy of donepezil hydrochloride combined with nimodipine on treating vascular dementia
Background: Vascular dementia (VaD) is a comprehensive syndrome related to the damage of cognitive function and various cerebral vascular illnesses. VaD is also generally recognized as the second most common type of dementia after Alzheimer disease, contributing to 30% of the dementia population in Asia and developing countries. The ability of donepezil hydrochloride and nimodipine had been respectively proven in improving cognitive function in vascular dementia. However, whether the combined application of both drugs contribute to better efficacy remains as a research hotspot. Studies had shown definite satisfactory result with such combination, however evidence-based evaluation of the efficacy is still lacking. Therefore, meta-analysis is employed in this study to evaluate the efficacy and safety of using donepezil hydrochloride combined with nimodipine in treating VaD to provide references for clinical treatments. The efficacy of donepezil hydrochloride combined with nimodipine on treating vascular dementia is systematically reviewed to provide evidence-based references for clinical applications. Methods: Both Chinese and English databases were searched from the start till August, 2020 for any RCT regarding the combined use of the 2 drugs in treating vascular dementia. Two investigators would later evaluate and screened out research and data based on an improved Jaded scale. Software Rev Man 5.3.0 was employed to carry out meta-analysis on clinical effificacy, mini-mental state examination (MMSE) ratings, activity of daily living (ADL) ratings, and clinical dementia scale (CDR) ratings. Results: Donepezil hydrochloride combined with nimodipine had demonstrated satisfactory efficacy on the treatment of vascular dementia. Improvements were namely spotted on MMSE scale, ADL scale, and CDR scale, with the utmost efficacy by 12 weeks after intervention. Conclusions: Donepezil hydrochloride combined with nimodipine had good efficacy in the treatment of patients with vascular dementia, mainly in terms of improving the Simple MMSE scores, the ability to use daily living scale (ADL) scores and the CDR, and the best results were obtained after 12 weeks of intervention. Such conclusion should be cautiously evaluated.
- 5 August 2022
- Published by Wolters Kluwer Health in Medicine
- Vol. 101 (31) , e29307
Open AccessA systematic review of the efficacy of donepezil hydrochloride combined with nimodipine on treating vascular dementia
Background: Vascular dementia (VaD) is a comprehensive syndrome related to the damage of cognitive function and various cerebral vascular illnesses. VaD is also generally recognized as the second most common type of dementia after Alzheimer disease, contributing to 30% of the dementia population in Asia and developing countries. The ability of donepezil hydrochloride and nimodipine had been respectively proven in improving cognitive function in vascular dementia. However, whether the combined application of both drugs contribute to better efficacy remains as a research hotspot. Studies had shown definite satisfactory result with such combination, however evidence-based evaluation of the efficacy is still lacking. Therefore, meta-analysis is employed in this study to evaluate the efficacy and safety of using donepezil hydrochloride combined with nimodipine in treating VaD to provide references for clinical treatments. The efficacy of donepezil hydrochloride combined with nimodipine on treating vascular dementia is systematically reviewed to provide evidence-based references for clinical applications. Methods: Both Chinese and English databases were searched from the start till August, 2020 for any RCT regarding the combined use of the 2 drugs in treating vascular dementia. Two investigators would later evaluate and screened out research and data based on an improved Jaded scale. Software Rev Man 5.3.0 was employed to carry out meta-analysis on clinical effificacy, mini-mental state examination (MMSE) ratings, activity of daily living (ADL) ratings, and clinical dementia scale (CDR) ratings. Results: Donepezil hydrochloride combined with nimodipine had demonstrated satisfactory efficacy on the treatment of vascular dementia. Improvements were namely spotted on MMSE scale, ADL scale, and CDR scale, with the utmost efficacy by 12 weeks after intervention. Conclusions: Donepezil hydrochloride combined with nimodipine had good efficacy in the treatment of patients with vascular dementia, mainly in terms of improving the Simple MMSE scores, the ability to use daily living scale (ADL) scores and the CDR, and the best results were obtained after 12 weeks of intervention. Such conclusion should be cautiously evaluated.
- Open Access
- 1 May 2022
- Published by Wolters Kluwer Health in Medicine: Case Reports and Study Protocols
- Vol. 3 (5) , e0224
Efficacy and safety of Chinese herbal medicine for vascular dementia
Introduction: As a common type of clinical dementia, the prevalence rate of vascular dementia (VaD) increased rapidly in recent years, damaging both patients’ health and social-economic prospect. There is currently no effective treatment for VaD, though western medicines can slightly improve patients’ cognitive function, but not brought a significant improvement in daily life ability. Chinese herbal medicine (CHM) has been widely employed to treat dementia for more than 2000years in China. Despite the proliferation of relevant literature, there is still a lack of evidence to prove the effectiveness and safety of such therapy. Therefore, this systematic review and meta-analysis protocol is aimed to assess the efficacy and safety of CHM for VaD. Methods and analysis: Six English databases (PubMed, Web of Science, Embase, Springer, CENTRAL and WHO International Clinical Trials Registry Platform) and 4 Chinese databases (Wan fang Database, Chinese Scientific Journals Database , China National Knowledge Infrastructure Database and Chinese Biomedical Literature Database ) will be searched from the inception to July 1st, 2020. Randomized controlled trials, which participants with VaD receiving various CHM therapy versus control group, will be included in this study. Two researchers will independently obtain data, screen eligible trials, and evaluate the quality of literature. Any disagreement will be settled by a discussion with the third investigator. A comprehensive meta-analysis will be conducted using the Cochrane collaboration software (Review Manager 5.3). Ethics and dissemination: Since this article is a protocol that does not involve patients and personal information collection, ethical approval is therefore not required. This systematic review will be published in a peer-reviewed journal, presented at conferences, and will be shared on social media platforms. The review will be disseminated in a peer-reviewed journal or conference presentation. INPLASY registration number: INPLASY 202210098.
- 1 May 2022
- Published by Wolters Kluwer Health in Medicine: Case Reports and Study Protocols
- Vol. 3 (5) , e0224
Open AccessEfficacy and safety of Chinese herbal medicine for vascular dementia
Introduction: As a common type of clinical dementia, the prevalence rate of vascular dementia (VaD) increased rapidly in recent years, damaging both patients’ health and social-economic prospect. There is currently no effective treatment for VaD, though western medicines can slightly improve patients’ cognitive function, but not brought a significant improvement in daily life ability. Chinese herbal medicine (CHM) has been widely employed to treat dementia for more than 2000years in China. Despite the proliferation of relevant literature, there is still a lack of evidence to prove the effectiveness and safety of such therapy. Therefore, this systematic review and meta-analysis protocol is aimed to assess the efficacy and safety of CHM for VaD. Methods and analysis: Six English databases (PubMed, Web of Science, Embase, Springer, CENTRAL and WHO International Clinical Trials Registry Platform) and 4 Chinese databases (Wan fang Database, Chinese Scientific Journals Database , China National Knowledge Infrastructure Database and Chinese Biomedical Literature Database ) will be searched from the inception to July 1st, 2020. Randomized controlled trials, which participants with VaD receiving various CHM therapy versus control group, will be included in this study. Two researchers will independently obtain data, screen eligible trials, and evaluate the quality of literature. Any disagreement will be settled by a discussion with the third investigator. A comprehensive meta-analysis will be conducted using the Cochrane collaboration software (Review Manager 5.3). Ethics and dissemination: Since this article is a protocol that does not involve patients and personal information collection, ethical approval is therefore not required. This systematic review will be published in a peer-reviewed journal, presented at conferences, and will be shared on social media platforms. The review will be disseminated in a peer-reviewed journal or conference presentation. INPLASY registration number: INPLASY 202210098.
- Top Cited PapersOpen Access
- 3 February 2022
- Published by Elsevier in Journal of Affective Disorders
- Vol. 303, 52-57
Association of depressive symptoms with marital status among the middle-aged and elderly in Rural China–Serial mediating effects of sleep time, pain and life satisfaction
- 3 February 2022
- Published by Elsevier in Journal of Affective Disorders
- Vol. 303, 52-57
Top Cited PapersOpen AccessAssociation of depressive symptoms with marital status among the middle-aged and elderly in Rural China–Serial mediating effects of sleep time, pain and life satisfaction
- 18 January 2022
- Published by International Platform of Registered Systematic Review and Meta-analysis Protocols (INPLASY)
Efficacy and safety of Chinese Herbal Medicine for Vascular dementia: A protocol of systematic review and meta-analysis
Review question / Objective: As a common type of clinical dementia, the prevalence rate of vascular dementia(VaD) increased rapidly in recent years, damaging both patients’ health and social-economic prospect. There is currently no effective treatment for VaD, though western medicines can slightly improve patients' cognitive function, but not brought a significant improvement in daily life ability. Chinese herbal medicine(CHM) has been widely employed to treat dementia for more than 2000 years in China. Despite the proliferation of relevant literature, there is still a lack of evidence to prove the effectiveness and safety of such therapy. Therefore, this systematic review and meta-analysis protocol is aimed to assess the efficacy and safety of CHM forVaD. Information sources: 6 English databases (PubMed, Web of Science, Embase, Springer, CENTRAL and WHO International Clinical Trials Registry Platform) and 4 Chinese databases (Wan fang Database, Chinese Scientific Journals Database, China National Knowledge Infrastructure Database and Chinese Biomedical Literature Database).
- 18 January 2022
- Published by International Platform of Registered Systematic Review and Meta-analysis Protocols (INPLASY)
Efficacy and safety of Chinese Herbal Medicine for Vascular dementia: A protocol of systematic review and meta-analysis
Review question / Objective: As a common type of clinical dementia, the prevalence rate of vascular dementia(VaD) increased rapidly in recent years, damaging both patients’ health and social-economic prospect. There is currently no effective treatment for VaD, though western medicines can slightly improve patients' cognitive function, but not brought a significant improvement in daily life ability. Chinese herbal medicine(CHM) has been widely employed to treat dementia for more than 2000 years in China. Despite the proliferation of relevant literature, there is still a lack of evidence to prove the effectiveness and safety of such therapy. Therefore, this systematic review and meta-analysis protocol is aimed to assess the efficacy and safety of CHM forVaD. Information sources: 6 English databases (PubMed, Web of Science, Embase, Springer, CENTRAL and WHO International Clinical Trials Registry Platform) and 4 Chinese databases (Wan fang Database, Chinese Scientific Journals Database, China National Knowledge Infrastructure Database and Chinese Biomedical Literature Database).
- Open Access
- 22 May 2021
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2021, 1-12
Efficacy and Safety of Scalp Acupuncture for Insomnia: A Systematic Review and Meta-Analysis
Objective. To systematically evaluate the efficacy and safety of scalp acupuncture in the treatment of insomnia. Methods. CNKI, Wanfang database, CQVIP database, CBM, Web of Science, Cochrane Library, and PubMed were searched for the literature on the treatment of insomnia by scalp acupuncture from the establishment of the database to July 23, 2020. Two researchers independently screened the literatures and extracted the data, then evaluated the quality of the literatures, and used RevMan 5.3 software for statistical analysis. Results. A total of 21 studies including 1606 cases were included. 21 studies were included in the analysis of effective rate. The heterogeneity test showed that there was no significant heterogeneity. The fixed effect model was used, < 0.00001. The effective rate of scalp acupuncture in the treatment of insomnia was significantly higher than that of the control group. The analysis of PSQI score was finally included in 19 studies. The heterogeneity test showed that there was obvious heterogeneity. The random effect model was used, and the subgroup analysis was conducted according to the different intervention measures of the control group. The values of the drug group and the blank group were both less than 0.05, indicating that the improvement of PSQI score in the scalp acupuncture treatment of insomnia was significantly better than that in the drug group and the blank group; = 0.05 in other acupuncture groups, suggesting in scalp acupuncture treatment, there was no difference between insomnia and other acupuncture in improving the PSQI score. Six studies were included in the analysis of adverse events. The heterogeneity test showed no significant heterogeneity. The fixed effect model was used, = 0.04 < 0.05, indicating that the adverse events of scalp acupuncture in the treatment of insomnia were better than those of the control group. No publication bias analysis was conducted due to the small number of adverse events included. Publication bias was analyzed for effective rate and PSQI score. Egger’s TSTs test (effective rate = 0.001, PSQI score = 0.001) and funnel plot showed publication bias. Conclusion. Scalp acupuncture is effective and safe in the treatment of insomnia, which is worthy of clinical application. However, due to the limited number of included literature, the methodology of some studies is slightly low and the quality of literature is slightly poor. In the future, we need to design rigorous, large sample, multiple center randomized controlled study to further verify the conclusion of this study.
- 22 May 2021
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2021, 1-12
Open AccessEfficacy and Safety of Scalp Acupuncture for Insomnia: A Systematic Review and Meta-Analysis
Objective. To systematically evaluate the efficacy and safety of scalp acupuncture in the treatment of insomnia. Methods. CNKI, Wanfang database, CQVIP database, CBM, Web of Science, Cochrane Library, and PubMed were searched for the literature on the treatment of insomnia by scalp acupuncture from the establishment of the database to July 23, 2020. Two researchers independently screened the literatures and extracted the data, then evaluated the quality of the literatures, and used RevMan 5.3 software for statistical analysis. Results. A total of 21 studies including 1606 cases were included. 21 studies were included in the analysis of effective rate. The heterogeneity test showed that there was no significant heterogeneity. The fixed effect model was used, < 0.00001. The effective rate of scalp acupuncture in the treatment of insomnia was significantly higher than that of the control group. The analysis of PSQI score was finally included in 19 studies. The heterogeneity test showed that there was obvious heterogeneity. The random effect model was used, and the subgroup analysis was conducted according to the different intervention measures of the control group. The values of the drug group and the blank group were both less than 0.05, indicating that the improvement of PSQI score in the scalp acupuncture treatment of insomnia was significantly better than that in the drug group and the blank group; = 0.05 in other acupuncture groups, suggesting in scalp acupuncture treatment, there was no difference between insomnia and other acupuncture in improving the PSQI score. Six studies were included in the analysis of adverse events. The heterogeneity test showed no significant heterogeneity. The fixed effect model was used, = 0.04 < 0.05, indicating that the adverse events of scalp acupuncture in the treatment of insomnia were better than those of the control group. No publication bias analysis was conducted due to the small number of adverse events included. Publication bias was analyzed for effective rate and PSQI score. Egger’s TSTs test (effective rate = 0.001, PSQI score = 0.001) and funnel plot showed publication bias. Conclusion. Scalp acupuncture is effective and safe in the treatment of insomnia, which is worthy of clinical application. However, due to the limited number of included literature, the methodology of some studies is slightly low and the quality of literature is slightly poor. In the future, we need to design rigorous, large sample, multiple center randomized controlled study to further verify the conclusion of this study.
- 20 May 2010
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 28 (15_suppl) , 5558
Combined hedgehog and epidermal growth factor receptor (EGFR) inhibition in a direct patient tumor model (DPTM) of head and neck squamous cell cancer (HNSCC).
5558 Background: A DPTM of HNSCC was established to optimally test novel therapies and the role of cancer stem cells (CSC) in relapses after therapy. This study examines the role of the Hedgehog pathway (HhP) in HNSCC and the effect of the smoothened (SMO) inhibitor IPI-926 alone and combined with the EGFR inhibitor cetuximab (Cet). Methods: Mouse models generated from implanted HNSCC surgical cases were optimized for a combination of factors (e.g. mouse strain, tumor location) yielding the most similar tumor to the parental cancer using morphologic, stroma invasion and gene expression analysis. Results: Tumor fragments from 25 cases were implanted with a 65% engraftment rate. An unbiased gene analysis comparing pathways enriched in 42 HNSCC and 14 head and neck normal tissues showed enrichment for the HhP in the cancers. IHC staining for the ligand sonic hedgehog (SHH) of a tissue array of 60 HNSCC and 20 normal tissues indicated that 65% were positive (++) or very positive (+++) and only 35% of the cancers were negative or faint (+), while 78% of normal tissues were negative for SHH. Samples from 3 DPTM and 3 cell line-derived xenografts were positive for SHH. Four DPTMs were treated in vivo with Cet, IPI-926, and the combination. IPI-926 had activity (T/C <40%) in two cases, and both Cet and the combination induced regressions in three. Whereas in all cases Cet-treated tumors re-grew 4-8 weeks post-therapy, combination- treated mice were relapse-free 3 months post-therapy. To test if Cet leads to CSC accumulation, putative CSC markers were measured by flow cytometry. CD24/44 and CD24/ALDH cells accumulated in Cet-treated tumors but decreased in combination-treated tumors. Implanted CD24/44 and CD24/ALDH positive cells generated tumors at a higher rate than negative cells despite a 100-fold cell dilution. These subgroups expressed SMO and GLI1 genes 200-fold and 700-fold higher than negative cells, respectively. Conclusions: The HhP is activated in HNSCC, with over-expression seen in the CSC subpopulation, where data suggests autologous signaling. When combined with Cet, HhP inhibition with IPI-926 diminishes CSC and prevents tumor relapse in a DPTM of HNSCC.
- 20 May 2010
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 28 (15_suppl) , 5558
Combined hedgehog and epidermal growth factor receptor (EGFR) inhibition in a direct patient tumor model (DPTM) of head and neck squamous cell cancer (HNSCC).
5558 Background: A DPTM of HNSCC was established to optimally test novel therapies and the role of cancer stem cells (CSC) in relapses after therapy. This study examines the role of the Hedgehog pathway (HhP) in HNSCC and the effect of the smoothened (SMO) inhibitor IPI-926 alone and combined with the EGFR inhibitor cetuximab (Cet). Methods: Mouse models generated from implanted HNSCC surgical cases were optimized for a combination of factors (e.g. mouse strain, tumor location) yielding the most similar tumor to the parental cancer using morphologic, stroma invasion and gene expression analysis. Results: Tumor fragments from 25 cases were implanted with a 65% engraftment rate. An unbiased gene analysis comparing pathways enriched in 42 HNSCC and 14 head and neck normal tissues showed enrichment for the HhP in the cancers. IHC staining for the ligand sonic hedgehog (SHH) of a tissue array of 60 HNSCC and 20 normal tissues indicated that 65% were positive (++) or very positive (+++) and only 35% of the cancers were negative or faint (+), while 78% of normal tissues were negative for SHH. Samples from 3 DPTM and 3 cell line-derived xenografts were positive for SHH. Four DPTMs were treated in vivo with Cet, IPI-926, and the combination. IPI-926 had activity (T/C <40%) in two cases, and both Cet and the combination induced regressions in three. Whereas in all cases Cet-treated tumors re-grew 4-8 weeks post-therapy, combination- treated mice were relapse-free 3 months post-therapy. To test if Cet leads to CSC accumulation, putative CSC markers were measured by flow cytometry. CD24/44 and CD24/ALDH cells accumulated in Cet-treated tumors but decreased in combination-treated tumors. Implanted CD24/44 and CD24/ALDH positive cells generated tumors at a higher rate than negative cells despite a 100-fold cell dilution. These subgroups expressed SMO and GLI1 genes 200-fold and 700-fold higher than negative cells, respectively. Conclusions: The HhP is activated in HNSCC, with over-expression seen in the CSC subpopulation, where data suggests autologous signaling. When combined with Cet, HhP inhibition with IPI-926 diminishes CSC and prevents tumor relapse in a DPTM of HNSCC.